Study investigating a standard treatment in kidney transplant patients versus a treatment with Certican® in combination with Cyclosporin A or Tacrolimus

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005238-21

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To demonstrate non-inferiority in renal function assessed by glomerular filtration rate (Nankivell formula) in at least one of the Certican® treatment regimens compared to the standard group at month 12 post-transplantation in renal transplant patients.


Critère d'inclusion

  • Kidney Transplantation

Liens